Successful Treatment of KIT D816v-Positive, Imatinib-Resistant Systemic Mastocytosis With Interferon-Alpha

Internal Medicine- Japan

doi 10.2169/internalmedicine.48.2294

Full Text

Abstract

Available in

Date

Authors

Publisher

Japanese Society of Internal Medicine

Related search

Single-Cell Analysis Reveals the KIT D816V Mutation in Haematopoietic Stem and Progenitor Cells in Systemic Mastocytosis

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Soluble Siglec-8 Levels Are Detectable in Subjects With Myeloid Variant Hypereosinophilic Syndromes, but Not in Those With D816V KIT + Systemic Mastocytosis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Advanced Systemic Mastocytosis: The Impact of KIT Mutations in Diagnosis, Treatment, and Progression

European Journal of Haematology
MedicineHematology
2013English

"Occult" Mastocytosis With Activating C-Kit Point Mutation Evolving Into Systemic Mastocytosis Associated With Plasma Cell Myeloma and Secondary Amyloidosis

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Interferon Alpha in Systemic Lupus Erythematosus

Journal of Biomedicine and Biotechnology
2010English

Systemic Mastocytosis

2020English

Gene Expression Profiling of Human C-Kit Mutant D816V

Journal of Cancer Therapy
2016English

An Analysis of Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations

Mathematical Biosciences
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology SimulationImmunologyBiological SciencesMedicineAgriculturalModeling
2015English

Aggressive Systemic Mastocytosis

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy